Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

HIV-1 RNA concentration and cognitive performance in a cohort of HIV-positive people.

Vitiello B, Goodkin K, Ashtana D, Shapshak P, Atkinson JH, Heseltine PN, Eaton E, Heaton R, Lyman WD.

AIDS. 2007 Jul 11;21(11):1415-22.

PMID:
17589187
2.

Cerebrospinal and peripheral human immunodeficiency virus type 1 load in a multisite, randomized, double-blind, placebo-controlled trial of D-Ala1-peptide T-amide for HIV-1-associated cognitive-motor impairment.

Goodkin K, Vitiello B, Lyman WD, Asthana D, Atkinson JH, Heseltine PN, Molina R, Zheng W, Khamis I, Wilkie FL, Shapshak P.

J Neurovirol. 2006 Jun;12(3):178-89.

PMID:
16877299
3.

New two-amino acid insertion near codon 70 of the HIV type 1 protease gene.

Winters MA, Kagan RM, Heseltine PN, Merigan TC.

AIDS Res Hum Retroviruses. 2005 Apr;21(4):311-3.

PMID:
15943574
4.

Structural analysis of an HIV-1 protease I47A mutant resistant to the protease inhibitor lopinavir.

Kagan RM, Shenderovich MD, Heseltine PN, Ramnarayan K.

Protein Sci. 2005 Jul;14(7):1870-8. Epub 2005 Jun 3.

5.
6.

Increasing prevalence of HIV-1 reverse transcriptase mutation K65R correlates with tenofovir utilization.

Kagan RM, Merigan TC, Winters MA, Heseltine PN.

Antivir Ther. 2004 Oct;9(5):827-8. No abstract available.

PMID:
15535422
7.
8.

Structure-based phenotyping predicts HIV-1 protease inhibitor resistance.

Shenderovich MD, Kagan RM, Heseltine PN, Ramnarayan K.

Protein Sci. 2003 Aug;12(8):1706-18.

9.

Infection and risk of ischemic stroke: differences among stroke subtypes.

Paganini-Hill A, Lozano E, Fischberg G, Perez Barreto M, Rajamani K, Ameriso SF, Heseltine PN, Fisher M.

Stroke. 2003 Feb;34(2):452-7.

PMID:
12574559
10.

In vitro activities of nontraditional antimicrobials against multiresistant Acinetobacter baumannii strains isolated in an intensive care unit outbreak.

Appleman MD, Belzberg H, Citron DM, Heseltine PN, Yellin AE, Murray J, Berne TV.

Antimicrob Agents Chemother. 2000 Apr;44(4):1035-40.

11.

Randomized double-blind placebo-controlled trial of peptide T for HIV-associated cognitive impairment.

Heseltine PN, Goodkin K, Atkinson JH, Vitiello B, Rochon J, Heaton RK, Eaton EM, Wilkie FL, Sobel E, Brown SJ, Feaster D, Schneider L, Goldschmidts WL, Stover ES.

Arch Neurol. 1998 Jan;55(1):41-51.

PMID:
9443710
12.

Nystatin prophylaxis.

Dubé MP, Heseltine PN, Rinaldi MG.

Clin Microbiol Rev. 1997 Apr;10(2):368. No abstract available.

13.

Meropenem versus tobramycin with clindamycin in the antibiotic management of patients with advanced appendicitis.

Berne TV, Yellin AE, Appleman MD, Heseltine PN, Gill MA.

J Am Coll Surg. 1996 May;182(5):403-7.

PMID:
8620275
14.

Unrecognized HIV-1 infection in inner-city hospital emergency department patients.

Nagachinta T, Gold CR, Cheng F, Heseltine PN, Kerndt PR.

Infect Control Hosp Epidemiol. 1996 Mar;17(3):174-7.

PMID:
8708358
15.

University of Southern California Repeatable Episodic Memory Test.

Parker ES, Eaton EM, Whipple SC, Heseltine PN, Bridge TP.

J Clin Exp Neuropsychol. 1995 Dec;17(6):926-36.

PMID:
8847398
16.

Pharmacoeconomics of piperacillin/tazobactam and imipenem/cilastatin in the treatment of patients with intra-abdominal infections.

Jhee SS, Gill MA, Yellin AE, Berne TV, Heseltine PN, Appleman MD.

Clin Ther. 1995 Jan-Feb;17(1):126-35.

PMID:
7758055
17.

Pharmacokinetics of meropenem in patients with intra-abdominal infections.

Bedikian A, Okamoto MP, Nakahiro RK, Farino J, Heseltine PN, Appleman MD, Yellin AE, Berne TV, Gill MA.

Antimicrob Agents Chemother. 1994 Jan;38(1):151-4.

18.

Fungemia and colonization with nystatin-resistant Candida rugosa in a burn unit.

Dubé MP, Heseltine PN, Rinaldi MG, Evans S, Zawacki B.

Clin Infect Dis. 1994 Jan;18(1):77-82.

PMID:
8054438
19.

Prospective randomized study of two different doses of clindamycin admixed with gentamicin in the management of perforated appendicitis.

Yellin AE, Berne TV, Heseltine PN, Appleman MD, Gill M, Chin A, Baker FJ.

Am Surg. 1993 Apr;59(4):248-55.

PMID:
8489087
20.

A randomized study of cefepime versus the combination of gentamicin and mezlocillin as an adjunct to surgical treatment in patients with acute cholecystitis.

Yellin AE, Berne TV, Appleman MD, Heseltine PN, Gill MA, Okamoto MP, Baker FJ, Holcomb C.

Surg Gynecol Obstet. 1993;177 Suppl:23-9; discussion 35-40.

PMID:
8256188
21.

A clinical comparison of cefepime and metronidazole versus gentamicin and clindamycin in the antibiotic management of surgically treated advanced appendicitis.

Berne TV, Yellin AE, Appleman MD, Heseltine PN, Gill MA.

Surg Gynecol Obstet. 1993;177 Suppl:18-22; discussion 35-40.

PMID:
8256187
22.

Tissue concentrations of cefepime in acute cholecystitis patients.

Okamoto MP, Gill MA, Nakahiro RK, Chin A, Yellin AE, Berne TV, Sclar DA, Knupp CA, Heseltine PN, Appleman MD.

Ther Drug Monit. 1992 Jun;14(3):220-5.

PMID:
1412608
23.

Eflornithine treatment of refractory Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome.

Paulson YJ, Gilman TM, Heseltine PN, Sharma OP, Boylen CT.

Chest. 1992 Jan;101(1):67-74.

PMID:
1729113
24.

Epidemiological spectrum and current treatment of listeriosis.

Cherubin CE, Appleman MD, Heseltine PN, Khayr W, Stratton CW.

Rev Infect Dis. 1991 Nov-Dec;13(6):1108-14.

PMID:
1775844
25.

Susceptibility testing of Listeria monocytogenes. A reassessment of bactericidal activity as a predictor for clinical outcome.

Appleman MD, Cherubin CE, Heseltine PN, Stratton CW.

Diagn Microbiol Infect Dis. 1991 Jul-Aug;14(4):311-7.

PMID:
1909614
27.

Intramuscular imipenem as adjuvant therapy for acute cholecystitis and perforated or gangrenous appendicitis.

Yellin AE, Heseltine PN, Berne TV, Appleman MD, Gill MA, Chenella FC.

Chemotherapy. 1991;37 Suppl 2:37-43.

PMID:
1879186
28.

Results of extended peptide T administration in AIDS and ARC patients.

Bridge TP, Heseltine PN, Parker ES, Eaton EM, Ingraham LJ, McGrail ML, Goodwin FK.

Psychopharmacol Bull. 1991;27(3):237-45.

PMID:
1775594
29.

Analysis of cefepime tissue penetration into human appendix.

Okamoto MP, Chin A, Gill MA, Yellin AE, Berne TV, Heseltine PN, Appleman MD, Knupp CA, Sclar DA.

Pharmacotherapy. 1991;11(5):353-8.

PMID:
1745620
30.

Intraoperative concentrations of ofloxacin in serum, bile fluid, and gallbladder wall tissue.

Chin A, Okamoto MP, Gill MA, Sclar DA, Berne TV, Yellin AE, Heseltine PN, Appleman MD.

Antimicrob Agents Chemother. 1990 Dec;34(12):2354-7.

31.

Ceftazidime/clindamycin versus tobramycin/clindamycin in the treatment of intra-abdominal infections.

Bubrick MP, Heim-Duthoy KL, Yellin AE, Berne TV, Heseltine PN, Appleman MD, Cocchetto DM, Matzke GR.

Am Surg. 1990 Oct;56(10):613-7.

PMID:
2221611
32.

Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. California Collaborative Treatment Group.

Chiu J, Nussbaum J, Bozzette S, Tilles JG, Young LS, Leedom J, Heseltine PN, McCutchan JA.

Ann Intern Med. 1990 Sep 1;113(5):358-61.

PMID:
2382918
33.

Comparison of two microcomputer Bayesian pharmacokinetic programs for predicting serum gentamicin concentrations.

Okamoto MP, Chin A, Gill MA, Yellin AE, Berne TV, Heseltine PN, Appleman MD.

Clin Pharm. 1990 Sep;9(9):708-11. No abstract available.

PMID:
2225751
34.

Fatal pulmonary infection with Mycobacterium fortuitum.

Nussbaum JM, Heseltine PN.

West J Med. 1990 Apr;152(4):423-5. No abstract available.

35.

Treatment of intra-abdominal infections: cost comparison of ampicillin/sulbactam and clindamycin/gentamicin.

Chin A, Gill MA, Ito MK, Yellin AE, Berne TV, Heseltine PN, Appleman MD.

Hosp Formul. 1990 Mar;25(3):295-6, 303-5.

PMID:
10103837
36.
37.

Controlled comparison of cefmetazole with cefoxitin for prophylaxis in elective cholecystectomy.

Berne TV, Yellin AE, Appleman MD, Gill MA, Chenella FC, Heseltine PN.

Surg Gynecol Obstet. 1990 Feb;170(2):137-40.

PMID:
2405523
38.

A multicenter clinical trial of oral ribavirin in HIV-infected patients with lymphadenopathy. The Ribavirin-LAS Collaborative Group.

Roberts RB, Dickinson GM, Heseltine PN, Leedom JM, Mansell PW, Rodriguez S, Johnson KM, Lubina JA, Makuch RW.

J Acquir Immune Defic Syndr. 1990;3(9):884-92. Erratum in: J Acquir Immune Defic Syndr 1991;4(4):450.

PMID:
1974628
39.

A multicenter clinical trial of oral ribavirin in HIV-infected people with lymphadenopathy: virologic observations. Ribavirin-LAS Collaborative Group.

Roberts RB, Hollinger FB, Parks WP, Rasheed S, Laurence J, Heseltine PN, Makuch RW, Lubina JA, Johnson KM.

AIDS. 1990 Jan;4(1):67-72.

PMID:
1690551
40.

Cost analysis of two clindamycin dosing regimens.

Chin A, Gill MA, Ito MK, Yellin AE, Berne TV, Heseltine PN, Appleman MD.

DICP. 1989 Dec;23(12):980-3.

PMID:
2603453
41.

A cost comparison of intramuscular versus intravenous imipenem.

Chin A, Gill MA, Ito MK, Yellin AE, Berne TV, Heseltine PN, Appleman MD.

Hosp Pharm. 1989 Nov;24(11):905-9.

PMID:
10296145
42.

Gentamicin-resistant pseudomonal infection. Rationale for a redefinition of ophthalmic antimicrobial sensitivities.

Ormerod LD, Heseltine PN, Alfonso E, Becker MI, Kenyon KR, Baerveldt G, Smith RE.

Cornea. 1989 Sep;8(3):195-9.

PMID:
2787230
43.

Improvement in AIDS patients on peptide T.

Bridge TP, Heseltine PN, Parker ES, Eaton E, Ingraham LJ, Gill M, Ruff M, Pert CB, Goodwin FK.

Lancet. 1989 Jul 22;2(8656):226-7. No abstract available.

PMID:
2568560
44.

Evaluation of two different dosage regimens of clindamycin and the penetration into human appendix.

Chin A, Gill MA, Ito MK, Yellin AE, Berne TV, Heseltine PN, Appleman MD, Chenella FC.

Ther Drug Monit. 1989;11(4):421-4.

PMID:
2741191
45.

Intraoperative serum, bile, and gallbladder-wall concentrations of cefmetazole in patients undergoing cholecystectomy.

Ito MK, Gill MA, Chenella FC, Berne TV, Yellin AE, Heseltine PN, Appleman MD.

Clin Pharm. 1988 Jun;7(6):467-8. No abstract available.

PMID:
3165314
46.

Norfloxacin in the eradication of enteric infections in AIDS patients.

Heseltine PN, Causey DM, Appleman MD, Corrado ML, Leedom JM.

Eur J Cancer Clin Oncol. 1988;24 Suppl 1:S25-8.

PMID:
3280324
47.

Compassionate use of norfloxacin.

Heseltine PN, Corrado ML.

Am J Med. 1987 Jun 26;82(6B):88-92.

PMID:
3605160
48.

Surgically treated gangrenous or perforated appendicitis. A comparison of aztreonam and clindamycin versus gentamicin and clindamycin.

Berne TV, Yellin AE, Appleman MD, Gill MA, Chenella FC, Heseltine PN.

Ann Surg. 1987 Feb;205(2):133-7.

49.

Eflornithine treatment of Pneumocystis carinii pneumonia in AIDS.

Gilman TM, Paulson YJ, Boylen CT, Heseltine PN, Sharma OP.

JAMA. 1986 Oct 24-31;256(16):2197-8. No abstract available.

PMID:
3093697
50.

The efficacy of cefoxitin vs. clindamycin/gentamicin in surgically treated stab wounds of the bowel.

Heseltine PN, Berne TV, Yellin AE, Gill MA, Appleman MD.

J Trauma. 1986 Mar;26(3):241-5.

PMID:
3951003

Supplemental Content

Loading ...
Support Center